Rce Technologies, Inc. announced it raised $20,000 in an initial filing from an offering of $500,000

Company

Location

About

RCE, an AI based med tech works towards the early detection of heart attacks. We have re-imagined the way cardiac proteins are monitored in the blood using a non-invasive transdermal technique. The instant reporting of one such protein, cardiac Troponin empowers emergency medicine physicians and cardiologists in the early assessment and appropriate risk stratification of patients presenting with chest pain. We currently conduct clinical studies and undertake premarket efforts.